LKL International Bhd (XKLS:0182) Research & Development: RM0.00 Mil (TTM As of Mar. 2026)


What is LKL International Bhd Research & Development?

LKL International Bhd XKLS:0182 -14.29% Research & Development is RM0.00 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. LKL International Bhd's Research & Development for the three months ended in Mar. 2026 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.00 Mil.

LKL International Bhd  (XKLS:0182) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

LKL International Bhd Research & Development Related Terms

LKL International Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for LKL International Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LKL International Bhd Research & Development Chart

LKL International Bhd Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Sep22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LKL International Bhd Quarterly Data
Oct20 Jan21 Jul21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LKL International Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.00 Mil mean?
LKL International Bhd (XKLS:0182) has a Research & Development of RM0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on LKL International Bhd and its competitors.
Is LKL International Bhd's Research & Development too high?
LKL International Bhd's current Research & Development is RM0.00 Mil.
How does LKL International Bhd's Research & Development compare to ISRG and BDX?
LKL International Bhd's Research & Development of RM0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on LKL International Bhd and its competitors. LKL International Bhd's current Research & Development is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.03 — trading 40% below its estimated fair value. The current Research & Development is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current Research & Development is RM0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LKL International Bhd Business Description

Address Wisma LKL, No.3, Jalan BS 7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, Seri Kembangan, SGR, MYS, 43300
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.